Funding boost
Imperial awarded £11.3 million for early stage clinical research
Imperial has been awarded £11.3 million by the National Institute of Health Research (NIHR) to support the delivery of clinical research.
Imperial awarded £11.3 million for early stage clinical research
Imperial has been awarded £11.3 million by the National Institute of Health Research (NIHR) to support the delivery of clinical research.
Survivors of heart attack plus cardiac arrest at increased risk of early death
Patients who survive a heart attack together with sudden cardiac arrest are at increased risk of dying within six years following hospital discharge.
Ultrasound scan can diagnose prostate cancer
An ultrasound scan can be used to detect cases of prostate cancer, according to new research.
Audio
Podcast: Debating vaccines, LGBTQ+ history month, and humans of health research
In this edition: A scientist countering vaccine misinformation, members of Imperial’s LGBTQ+ network, and the people behind an impactful asthma trial.
Portrait exhibition celebrates staff and patients in healthcare research
A new series of portraits documenting researchers and patients involved in healthcare research has been unveiled in an online photography exhibition.
Researchers awarded £1m to trial quicker diagnostic tools for prostate cancer
Researchers have been awarded £1 million to trial new MRI scanning methods to diagnose prostate cancer.
Sepsis risk alerts can help to protect patients in hospitals, research finds
A digital alert system to identify patients who are at risk of sepsis can reduce deaths and extended hospital stays, Imperial research has found.
Real-world data provides valuable insights into COVID vaccine roll-out
Analysis of Europe’s largest patient data record has provided valuable insights into the UK’s COVID-19 vaccine roll-out, an Imperial expert has said.
‘Issue of inequalities’ for long COVID patients needs to be addressed
The “big issue of inequalities” for long COVID patients who face ongoing symptoms and disability needs to be addressed, an expert has said.
Expert ‘optimistic’ about possibility of tests for long COVID
There are reasons to be “optimistic” about the possibility of creating simple tests to determine if someone has long COVID, an expert has said.